Mesonephric Gynecologic Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-12
Clinical Trial Update: A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer [Phase 2]
Phase 2 trial evaluating Avutometinib (VS-6766) in combination with Defactinib for mesonephric Gynecologic Cancer; recruitment is ongoing.